{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:45:06Z","timestamp":1779317106629,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,6]]},"DOI":"10.7759\/cureus.34699","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T02:10:52Z","timestamp":1675735852000},"source":"Crossref","is-referenced-by-count":6,"title":["Recurrent Strokes in a Patient With Metastatic Lung Cancer"],"prefix":"10.7759","author":[{"given":"Rohan","family":"Karkra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riya","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra P","family":"Shivaswamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Stroke. Hope through research. (2021). Accessed: January 27, 2023: https:\/\/www.ninds.nih.gov\/health-information\/patient-caregiver-education\/hope-through-research\/stroke-hope-through-re...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4669","article-title":"Cancer-associated stroke: pathophysiology, detection and management (Review)","volume":"54","author":"Dardiotis E","year":"2019","unstructured":"Dardiotis E, Aloizou AM, Markoula S, et al.. Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 2019, 54:779-96. 10.3892\/ijo.2019.4669","journal-title":"Int J Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.571356","article-title":"Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea","volume":"41","author":"Kim SG","year":"2010","unstructured":"Kim SG, Hong JM, Kim HY, et al.. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010, 41:798-801. 10.1161\/STROKEAHA.109.571356","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.016","article-title":"Trends in cancer diagnoses among inpatients hospitalized with stroke","volume":"22","author":"Sanossian N","year":"2013","unstructured":"Sanossian N, Djabiras C, Mack WJ, Ovbiagele B. Trends in cancer diagnoses among inpatients hospitalized with stroke. J Stroke Cerebrovasc Dis. 2013, 22:1146-50. 10.1016\/j.jstrokecerebrovasdis.2012.11.016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.615534","article-title":"Lung cancer and incidence of stroke: a population-based cohort study","volume":"42","author":"Chen PC","year":"2011","unstructured":"Chen PC, Muo CH, Lee YT, Yu YH, Sung FC. Lung cancer and incidence of stroke: a population-based cohort study. Stroke. 2011, 42:3034-9. 10.1161\/STROKEAHA.111.615534","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0300060516666398","article-title":"Clinical features and biological markers of lung cancer-associated stroke","volume":"44","author":"Xie X","year":"2016","unstructured":"Xie X, Chen L, Zeng J, Qin C, Cheng D, Wei X, Liang Z. Clinical features and biological markers of lung cancer-associated stroke. J Int Med Res. 2016, 44:1483-91. 10.1177\/0300060516666398","journal-title":"J Int Med Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2019.02278","article-title":"Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms","volume":"22","author":"Bang OY","year":"2020","unstructured":"Bang OY, Chung JW, Lee MJ, Seo WK, Kim GM, Ahn MJ. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke. 2020, 22:1-10. 10.5853\/jos.2019.02278","journal-title":"J Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102484","article-title":"Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis","volume":"9","author":"Zuo PY","year":"2014","unstructured":"Zuo PY, Chen XL, Liu YW, Xiao CL, Liu CY. Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis. PLoS One. 2014, 9:e102484. 10.1371\/journal.pone.0102484","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000546","article-title":"Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA","volume":"28","author":"Lysov Z","year":"2017","unstructured":"Lysov Z, Dwivedi DJ, Gould TJ, Liaw PC. Procoagulant effects of lung cancer chemotherapy: impact on microparticles and cell-free DNA. Blood Coagul Fibrinolysis. 2017, 28:72-82. 10.1097\/MBC.0000000000000546","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2738","article-title":"Cancer-related stroke: exploring personalized therapy strategies","volume":"12","author":"Chen YJ","year":"2022","unstructured":"Chen YJ, Dong RG, Zhang MM, Sheng C, Guo PF, Sun J. Cancer-related stroke: exploring personalized therapy strategies. Brain Behav. 2022, 12:e2738. 10.1002\/brb3.2738","journal-title":"Brain Behav"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700790","article-title":"Efficacy of neuroprotective drugs in acute ischemic stroke: is it helpful?","volume":"10","author":"Mehta A","year":"2019","unstructured":"Mehta A, Mahale R, Buddaraju K, Javali M, Acharya P, Srinivasa R. Efficacy of neuroprotective drugs in acute ischemic stroke: is it helpful?. J Neurosci Rural Pract. 2019, 10:576-81. 10.1055\/s-0039-1700790","journal-title":"J Neurosci Rural Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob GE","year":"2018","unstructured":"Raskob GE, van Es N, Verhamme P, et al.. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018, 378:615-24. 10.1056\/NEJMoa1711948","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)30369-2","article-title":"International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"17","author":"Farge D","year":"2016","unstructured":"Farge D, Bounameaux H, Brenner B, et al.. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2016, 17:452-66. 10.1016\/s1470-2045(16)30369-2","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/137127-recurrent-strokes-in-a-patient-with-metastatic-lung-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:32Z","timestamp":1707508712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/137127-recurrent-strokes-in-a-patient-with-metastatic-lung-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.34699","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,6]]}}}